Have a Topic Idea?

What would you like to see featured on MedConnect? Let us know.

Submit an Idea

FDA UPDATE: PIQRAY

FDA Approves First and Only Treatment for Common Mutation in Advanced Breast Cancer The FDA approved a new drug that is a potential game changer for advanced breast...

Dispelling the Myth: Generics Are Not Always Low Cost

  Dispelling the Myth: Generics Are Not Always Low Cost When we hear the terms “generic” or “off-brand,” we typically think that the product would be a...

National Prescription Drug Take Back Day Helps Fight Drug Abuse

National Prescription Drug Take Back Day Helps Fight Drug Abuse   +5,400 tons . That’s how much the DEA has collected of expired, unwanted or unused prescription...

MedImpact Sponsors the 12th Annual Minnesota Health Action Group Employer Leadership

Focused on the Future MedImpact Sponsors the 12th Annual Minnesota Health Action Group Employer Leadership Summit    As a healthcare company focused on...

An Aligned Partnership Drives Results

An Aligned Partnership Drives Results MedImpact helps Mercy Health realize $10.5 million in savings Mercy Health — the largest health system in Ohio — partnered with...

MedImpact sponsors MIT initiative to help make high-cost curative therapies more accessible

Paying for Cures MedImpact sponsors MIT initiative to help make high-cost curative therapies more accessible MedImpact will collaborate with healthcare leaders...

Combating the Opioid Crisis Together

Combating the Opioid Crisis Together MedImpact helps reduce opioid utilization in one of America's most affected states Alabama has the highest opioid prescribing...

MedImpact Selects ExtraHop to Drive Innovation and Improve Care

MedImpact Selects ExtraHop to Drive Innovation and Improve Care To help ensure the seamless delivery of pharmacy services and provide an optimal member experience,...

MedImpact Activates Natural Disaster Response in Wake of Hurricane Michael

MedImpact Activates Natural Disaster Response in Wake of Hurricane Michael As Hurricane Michael — the strongest hurricane in history to hit the Florida Panhandle —...

Hurricane Florence Support

Hurricane Florence Support Dispelling the Myth: Generics Are Not Always Low Cost MedImpact Helps Plans Save $30 Million in High-Cost Generic Spend   5 Facts...

FDA Approves New Preventive Treatment for Rare Hereditary Disease

FDA Approves New Preventive Treatment for Rare Hereditary Disease The U.S. Food and Drug Administration (FDA) recently approved Takhzyro (lanadelumab-flyo) as the first...

Moving Toward Performance-Based Networks

Moving Toward Performance-Based Networks MedImpact Discusses Trends in Value-Based Pharmacy Reimbursement In a recent issue of Chain Drugstore Daily , Dave...

Don’t Get Lost in the Crowded Orphan Drug Market

Don’t Get Lost in the Crowded Orphan Drug Market MedImpact Offers Insight on Managing Blockbuster Drugs MedImpact Expects Orphan Drug Approval to Increase ...

Biosimilar News Tops Industry Headlines

MedImpact’s Annual Trend Report Spotlights Oncology. Oncology received more new FDA approvals in 2017 than any other therapeutic class — and this trend will likely continue through 2018 and...

Spotlight on Multiple Sclerosis

Spotlight on Multiple Sclerosis As MS drugs continue to make headlines, MedImpact’s Annual Trend Report offers insights on trends As the number of people suffering...

FDA Approves First Preventive Treatment for Migraine

FDA Approves First Preventive Treatment for Migraine The U.S. Food and Drug Administration (FDA) recently approved Aimovig (erenumab-aooe), the first preventive treatment...

MedImpact Achieves Low Medicare & Medicaid Trend

MedImpact Achieves Low Medicare & Medicaid Trend in Spite of CMS Reports of Skyrocketing Drug Costs The Centers for Medicare & Medicaid Services (CMS) released this...